ONC Q3 2022 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q3 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$388M+87.8% YoY

Gross Profit

$311M80.3% margin

Operating Income

-$438M-113.1% margin

Net Income

-$558M-143.8% margin

EPS (Diluted)

$-5.33

QoQ Revenue Growth

+13.5%

Cash Flow

Operating Cash Flow

-$562M

Free Cash Flow

-$691M

Stock-Based Comp.

$78M

Balance Sheet

Total Assets

$6.7B

Total Liabilities

$2.1B

Stockholders' Equity

$4.7B

Cash & Equivalents

$4.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$388M	$206M	+87.8%
Gross Profit	$311M	$159M	+95.6%
Operating Income	-$438M	-$462M	+5.2%
Net Income	-$558M	-$438M	-27.3%